Strategic Blueprint’s Sanofi SNY Stock Holding History

Strategic Blueprint’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-200	Closed	-$11K	–	1175
2021 Q2	$11K	Buy	+200	New	+$10.4K	﹤0.01%	951
2019 Q4	–	Sell	-200	Closed	-$9K	–	365
2019 Q3	$9K	Buy	+200	New	+$8.63K	0.01%	312

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Strategic Blueprint's SNY Position: Q3 2021 in Review

Strategic Blueprint sold out of Sanofi (SNY) in Q3 2021, closing a stake of 200 shares — an estimated $11K sold.

Strategic Blueprint first reported a position in SNY in Q3 2019 and held it in 2 quarters. The position peaked at $11K in Q2 2021. 576 funds tracked by Wall St. Rank hold SNY as of Q3 2021.

Strategic Blueprint reported no remaining Sanofi position as of Q3 2021 after selling out during the quarter.
Strategic Blueprint sold 200 Sanofi shares in Q3 2021, an estimated $11K.
Strategic Blueprint first reported a position in Sanofi in Q3 2019 and held it in 2 quarters.
Strategic Blueprint's Sanofi position peaked at $11K in Q2 2021.
576 funds tracked by Wall St. Rank held Sanofi as of Q3 2021.

Based on Strategic Blueprint's 13F filing for Q3 2021, filed 12 Nov 2021.